2 news items
Enlivex Announces Topline Results Of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
ENLV
11 Apr 24
% for patients whose infection source was community-acquired pneumonia, and 36% for patients whose infection source was internal abdominal infection
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
ENLV
11 Apr 24
scores for sepsis patients whose infection source was urinary tract, 68% for patients whose infection source was community-acquired pneumonia, and 36
- Prev
- 1
- Next